, Tracking Stock Market Picks
Enter Symbol:
The Medicines Company (MDCO) [hlAlert]

up 72.55 %

The Medicines Company (MDCO) rated Buy with price target $20 by Argus

Posted on: Friday,  Aug 26, 2011  9:25 AM ET by Argus

Argus rated Buy The Medicines Company (NASDAQ: MDCO) on 08/26/2011. Previously Argus rated Buy The Medicines Company (NASDAQ: MDCO) on 06/09/2011.,
when the stock price was $18.40. Since then, The Medicines Company has gained 72.55% as of 01/15/2016's recent price of $31.75.
If you would have followed the previous Argus's recommendation on MDCO, you would have gained 72.55% of your investment in 1681 days.

The Medicines Company is a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of medicines to the worldwide hospital marketplace. The Company has two marketed products, Angiomax (bivalirudin) and Cleviprex (clevidipine butyrate) injectable emulsion, two products in late-stage development, cangrelor and oritavancin, which the Company acquired in February 2009, and one compound, CU-2010, scheduled to enter clinical development during 2009.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/26/2011 9:25 AM Buy
13.91 20.00
as of 12/30/2011
1 Week down  -2.51 %
1 Month down  -1.42 %
3 Months up  25.26 %
1 YTD up  34.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/9/2011 8:25 AM Buy
18.40 25.00
1/12/2009 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy